Synthekine picks up $82m Series A

Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing.

Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing. Canaan Partners, Samsara BioCapital and The Column Group led the round.

Source: Press Release